Fortress Companies

Home » Fortress companies » avenue therapeutics

Avenue Therapeutics, Inc.*

Avenue Therapeutics, Inc. (“Avenue”), founded by Fortress Biotech, is a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol for the management of moderate to moderately severe postoperative pain. IV tramadol may fill a gap in the acute pain market between IV acetaminophen/NSAIDs and IV conventional narcotics. Avenue is currently evaluating IV tramadol in a pivotal Phase 3 program for the management of postoperative pain. Avenue is headquartered in New York City.  

For more information, please visit

*Avenue Therapeutics, Inc. is an entity which was founded by Fortress and in which Fortress still maintains a large minority ownership position.